Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 301-320 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 301 | Emposat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only gives contextual membership rationale that Emposat provides ground-station access used in connection with a surveillance satellite, which is too indirect to support a durable positive investment thesis without direct within the recent evidence window business evidence. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat. Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard. |
| 302 | EnduroSat lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, despite membership rationale describing EnduroSat as a space infrastructure and satellite-constellation builder. Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here. Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment. |
| 303 | EON Space Labs lowweak | Opp 1 Risk 3 | Thesis: No positive thesis is supportable from the scoring evidence fields because no direct positive evidence are provided. Why now: Why now is stronger than for most names here because the phase2 rationale specifically ties EON Space Labs to a PSLV failure context via article: implying a concrete event rather than generic company context. However, conviction remains low because the reviewed sources omits the underlying event summary and dates in the evidence exposed here. Caveats: The adverse signal appears only in phase2 rationale, not in direct negative evidence. No article summary, quote, or timing detail is provided in the scoring fields. Impact magnitude on EON specifically cannot be quantified from these reviewed sources alone. |
| 304 | FOSSA Systems lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' membership rationale says FOSSA Systems has launched 24 satellites, is deploying an 80-satellite constellation, and has defense customers, but there are no available direct positive evidence or dated representative articles within the reviewed sources for scoring, so opportunity remains only a watchlist possibility. Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources. Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale. |
| 305 | GalaxEye Space Solutions Private Ltd lowweak | Opp 1 Risk 2 | Thesis: The company belongs in the cohort as an Earth observation / SAR startup, but these reviewed sources provide no available within the recent evidence window directional evidence to support a strong 1 year+ opportunity thesis. Why now: There is no within the recent evidence window evidence available for this entity in the reviewed sources; recency of any business progress is uncertain. Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff for this entity. Membership rationale references article IDs, and: but no article summaries or direct evidence are included in these reviewed sources for citation-level use. Scores are constrained by absence of directional evidence, not by a proven negative business outcome. |
| 306 | GE Aerospace lowweak | Opp 1 Risk 1 | Thesis: No reviewed sources-supported positive thesis is available. The company is only described as appearing in generic 'space stocks' context, while direct positive evidence after the 90-day recent evidence window is absent. Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported. Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement. |
| 307 | Gilat Satellite Networks Ltd. lowweak | Opp 1 Risk 1 | Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a positive 1 year+ opportunity thesis. Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources. Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them. |
| 308 | Hensoldt AG lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers no direct positive company-specific evidence within the available scoring set. The membership rationale says Hensoldt appears in a market report as one of many key players in the space situational awareness market, but that is article-level market-list context rather than direct business evidence, and no available evidence remain after recent evidence window. Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact. |
| 309 | HEO USA lowweak | Opp 1 Risk 1 | Thesis: A limited positive angle exists because the membership rationale says a HEO camera achieved sub-5-meter resolution in Sidus Space's earnings context, implying technical relevance (: and: unavailable in reviewed sources). However, this appears indirect and counterparty/component context rather than direct company evidence, so opportunity remains low. Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence. Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window. |
| 310 | Hermeus Corporation lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available. The reviewed sources say Hermeus is only mentioned as one of several companies expanding in California in an article about Skydio, which is too indirect to support a durable positive thesis. Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context. |
| 311 | HughesNet lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources places HughesNet within satellite broadband and communication services context via EchoStar, but there is no direct reviewed evidence in the 90-day window to support a differentiated 1 year+ opportunity thesis. Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible. Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources. |
| 312 | Impulso lowweak | Opp 1 Risk 1 | Thesis: There is no direct positive evidence in the available scoring set. The reviewed sources say Impulso is mentioned only as GalaxEye's distribution agreement counterparty, which does not establish Impulso's own business opportunity. Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis. |
| 313 | Infinite Orbits lowweak | Opp 1 Risk 1 | Thesis: Potential long-horizon opportunity exists if the previously referenced multi-launch agreement for servicing satellites remains active, but the reviewed sources provide no retained within the recent evidence window positive evidence to support a current thesis. Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established. Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence. |
| 314 | Integrate lowweak | Opp 1 Risk 1 | Thesis: No current positive thesis is supportable within the reviewed sources' retained recent evidence window evidence. Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026). Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale. |
| 315 | Integrated Launch Solutions, Inc. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from retained evidence because the reviewed sources contain no direct positive rows within the recent evidence window. Why now: No current catalyst is evidenced in retained rows. Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence. |
| 316 | Integrity ISR lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported because there is no retained direct positive evidence within the reviewed sources' recent evidence window. Why now: No current business change or catalyst is evidenced in the retained rows. Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing. |
| 317 | Israel Aerospace Industries lowweak | Opp 1 Risk 1 | Thesis: No admissible direct positive evidence was available inside the 90-day recent evidence window, so there is no supportable positive 1 year+ opportunity thesis from these reviewed sources alone. Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources. Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources. |
| 318 | Kepler Communications lowweak | Opp 1 Risk 1 | Thesis: Kepler may have long-horizon potential because the membership rationale says it operates an optical relay satellite network and is prime contractor on ESA HydRON optical communications work, but there is no available within the recent evidence window evidence in these reviewed sources to substantiate a directional score. Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company. Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain. |
| 319 | Kessler Dynamics lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence hints only that Kessler Dynamics was listed in a spacetech accelerator with themes including rocket propulsion, satellites, and space energy, but no in-recent evidence window direct evidence or article is provided, so there is no supported positive thesis. Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation. Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule. |
| 320 | KinetX lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available, so there is no supportable opportunity thesis from these reviewed sources alone. Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering. Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources. |
Risk view
Showing rows 361-380 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 361 | Safran lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources also does not provide direct adverse evidence within the available 90-day evidence set, so there is no basis for a material risk thesis beyond uncertainty from missing evidence coverage. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported. Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. |
| 362 | Sanyark Space Technologies lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is available. Risk is mainly that accelerator inclusion alone is too weak to support a durable company thesis, especially over a 1 year+ horizon without proof of funding, contracts, or product milestones (: not provided in reviewed sources). Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure. Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available. |
| 363 | SatLeo Labs lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale. Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window. |
| 364 | SatVu lowweak | Opp 2 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence is provided in the reviewed sources. Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy. Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score. |
| 365 | Scale AI lowweak | Opp 2 Risk 1 | Thesis: The risk case is limited by lack of direct adverse evidence in the reviewed sources; the primary risk is evidentiary rather than operational because no retained post-recent evidence window event details, award sizing to the company, or execution milestones are available. Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope. Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion. |
| 366 | Schaeffler AG lowweak | Opp 2 Risk 1 | Thesis: No material negative evidence is available within the reviewed sources recent evidence window. Risk remains low on evidence, not necessarily in reality. Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence. Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources. |
| 367 | SciTec lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is retained, leaving no evidence-based risk case. Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter. Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window. |
| 368 | SEALCOIN AG lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is retained. Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window. Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself. |
| 369 | SEALSQ Corp lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources also provides no retained material adverse evidence, leaving risk unsupported beyond baseline uncertainty. Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff. Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction. |
| 370 | SES S.A. lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available for SES. Risk score remains low because of lack of evidence, not because risk has been disproven. Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources. Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity. |
| 371 | Sidus Space Inc. lowweak | Opp 1 Risk 1 | Thesis: No within the recent evidence window direct negative evidence was available, so the reviewed sources does not support a material risk thesis. Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources. |
| 372 | SkyFi lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available, so there is no supportable downside thesis from these reviewed sources alone. Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided. Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 373 | Skyfora lowweak | Opp 1 Risk 1 | Thesis: There is no retained direct adverse evidence in the reviewed sources after recent evidence window, so any risk thesis would be speculative rather than evidence-based. Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded. Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof. |
| 374 | Solestial Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable from these reviewed sources because no retained direct negative evidence is provided inside the recent evidence window. Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window. Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof. |
| 375 | Solstar Space Company lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is available, so there is no supported adverse thesis from the evidence provided. Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status. Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative. |
| 376 | Space Mission Systems lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is available. The main risk is identity ambiguity and insufficient grounding rather than a demonstrated adverse development. Why now: The only potential 'why now' is contract-related context in the membership rationale, but it is not sufficiently tied to this entity and no dated scoring evidence with is available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Entity identification is unclear in the reviewed sources. |
| 377 | Space Systems/Loral, LLC (SSL) lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is available in the reviewed sources, so risk stays low purely due to missing evidence rather than demonstrated resilience. Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources. Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window. |
| 378 | Space42 lowweak | Opp 1 Risk 1 | Thesis: No retained adverse evidence is provided, so there is no material evidence-based risk thesis in these reviewed sources. Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window. Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. |
| 379 | Spaceflux lowweak | Opp 3 Risk 1 | Thesis: No material negative evidence is available. The main risk is that the cited funding amount may be too small to be strategically meaningful, but the reviewed sources does not provide direct adverse evidence or enough detail to rank this as a strong risk name (: not provided in reviewed sources). Why now: A follow-on investment could matter over 1 year+ if it extends development in debris tracking, but there is no available dated evidence within the recent evidence window and no direct article summary/ in the reviewed sources. Caveats: Only article-level rationale is available. Funding size may be modest, but reviewed sources does not provide enough context to judge materiality precisely. No representative article or quote available. |
| 380 | SpaceLocker lowweak | Opp 1 Risk 1 | Thesis: There is not enough retained evidence in the recent evidence window to support a material risk thesis. Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking. Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially. |